Currently there are clinical trials around the world being undertaken in many opthalmology fields including;

• Dry Eyes
• Macular Degeneration
• Glaucoma
• Optic Neuritis
• Diabetic retinopathy
• Optic nerve damage
• Retinitis pigmentosa
• Optic atrophy
• Stargardt’s
• Leber’s
• CRVO
• Corneal diseases
• Limbal stem cell deficiency
• Optic neuropathy
• Macular hole
• Retinal degeneration
• Plaquenil toxicity
• Non-healing corneal ulcers

These trials can take between 5 and 10 years to come to fruition, however the overwhelming understanding and results thus far are proving very successful. At Cellf we have studied these treatments and applied what we believe to be the most beneficial, non-invasive and safe protocols as our range of therapies. For more information please look at the many web sites available.

Cellf endeavours to help our patients to make informed decisions and offer the “Pros and Cons” in our full patient consultation process.

There are those in the medical and scientific professions that believe Cell Therapy should be banned until it has had the necessary trials. What the existing trials are showing is that by using the patient’s own cells in a fully enclosed unit there is no chance of rejection or contamination. And in some trials the worst outcome is no outcome. Unlike some treatments that are currently considered safe and effective with terrible side effects.

Please read the abstract below to understand how wrong we can sometimes be.

A few short decades ago it was widely believed that the brain had neither stem cells nor the ability to regenerate itself. We were warned against the dangers of everything from contact sports to drugs to break dancing with the cry: “Once you’ve lost your brain cells, you won’t get them back!” Then, in 1992, Perry Bartlett’s lab at the Walter and Eliza Hall Institute co-discovered stem cells in the adult brain that had the capacity to produce new neurons (nerve cells). This finding turned conventional wisdom on its head and brought a ray of hope to the millions of people with acquired brain injury or degenerative conditions of the brain such as dementia and Alzheimer’s disease.

Feel free to contact us at Cellf for more information relating to opthalmology.

It is important to remember that although “Cell Regeneration Therapy” is an outpatient procedure and has been seen as a viable treatment to help soothe symptoms of pain, Cellf can neither predict or guarantee success for individual patients who undergo the Therapies. There are potential risks associated with any medical procedure. Please discuss this with a medical practitioner prior to undergoing any procedures.